Enthera Pharmaceuticals extends its €28m Series A financing from last July to a total of €35m as Roche Venture Fund joins the company’s investor syndicate.
https://european-biotechnology.com/wp-content/uploads/2024/04/GeldLSP.jpg9721280Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2021-01-28 16:47:432021-01-28 16:47:43Italian Enthera Pharma raise €35m in Series A extension
https://european-biotechnology.com/wp-content/uploads/2024/04/novel-coronavirus-sars-cov-2_49666286236_o.jpg17862100Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2021-01-27 08:57:152021-01-27 08:57:15German antibodies in demand in USA
/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png00h.genrich/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngh.genrich2021-01-27 08:30:002021-01-27 08:30:00Accure Therapeutics named new CMO
https://european-biotechnology.com/wp-content/uploads/2024/04/Omnix_Medical.jpg320640Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2021-01-25 11:46:402021-01-25 11:46:40Omnix Medical bags €10.8m from EIC Accerator Fund
https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2021-01-25_um_10.38.27.png553949Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2021-01-25 10:23:502021-01-25 10:23:50Germany orders antibody therapies from USA
French Servier SA and the UK’s MiNA Therapeutics Ltd have entered into a R&D partnership to identify and develop small activating RNAs (saRNA) to treat neurological disorders.
Irish life sciences company Neurent Medical has closed a €21m Series B investment co-led by LSP as well as Atlantic Bridge with participation of Fountain Healthcare Partners.
https://european-biotechnology.com/wp-content/uploads/2024/04/Advertorial_CodexDNA_kl-scaled.jpg14402560Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2021-01-15 12:09:422024-04-02 15:35:34Automate your DNA variant library synthesis and reduce turnaround time from weeks and months to days and hours
Italian Enthera Pharma raise €35m in Series A extension
Latest NewsEnthera Pharmaceuticals extends its €28m Series A financing from last July to a total of €35m as Roche Venture Fund joins the company’s investor syndicate.
German antibodies in demand in USA
Latest NewsA US subsidiary of Hamburg-based Evotec SE has won a contract from the US government to produce antibodies against SARS-CoV-2.
Accure Therapeutics named new CMO
AppointmentsSpanish Accure Therapeutics appoints Dr Rossella Medori as new Chief Medical officer.
Omnix Medical bags €10.8m from EIC Accerator Fund
Latest NewsGermany orders antibody therapies from USA
Latest NewsGermany has become the first country in Europe to buy the US emergency-approved COVID-19 antibody therapies from Regeneron and Eli Lilly.
Servier and MiNA Therapeutics sign €220m deal
Latest NewsFrench Servier SA and the UK’s MiNA Therapeutics Ltd have entered into a R&D partnership to identify and develop small activating RNAs (saRNA) to treat neurological disorders.
LSP leads €21m round into Neurent Medical
Latest NewsIrish life sciences company Neurent Medical has closed a €21m Series B investment co-led by LSP as well as Atlantic Bridge with participation of Fountain Healthcare Partners.
Janssen presents one-shot COVID-19 vaccine data
Latest NewsJ&J subsidiary Janssen Pharma has presented updated Phase I/II antibody levels supporting a single shot administration for its COVID-19 vaccine.
Automate your DNA variant library synthesis and reduce turnaround time from weeks and months to days and hours
Sponsored PublicationsThe BioXp system is the world’s only automated platform for on-demand DNA assembly and amplification.
German researchers find reason for remdesivir’s inefficiency
Latest NewsGerman Researchers have unraveled how remdesivir interferes with the viral RNA polymerase and why it does not block SARS-CoV-2 completely.